Overview


FutureWise Market Research has instantiated a report that provides an intricate analysis of HIV Diagnosis and Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the HIV Diagnosis and Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Viiv Healthcare Group of Companies, Inc.
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd
  • Gilead
  • Glaxosmithkline Plc.
  • Hologic Inc.
  • Viiv Healthcare Group of Companies, Inc.
  • Janssen Diagnostics
  • Johnson & Johnson Services
  • Merck & Co. Inc.
  • Mylan Inc.
  • Qiagen
  • Roche Diagnostics
  • Siemens Healthcare
  • Sysmex Corporation
  • Zyomyx Inc.
  • Partec
  • Pointcare Technologies Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Test Type

  • Antibody Tests
  • Hiv-1 Screening Tests
  • Hiv-1 Antibody Confirmatory Tests
  • Hiv-2 and Group O Diagnostic Tests
  • Viral Identification Assays
  • Cd4 Testing
  • Viral Load Testing
  • Early Infant Diagnostics

By Diagnostic Product

  • Assays, Kits and Reagents
  • Instruments
  • Software and Service
  • Others (Poc and Single Blood Drop Analyser)

By Treatment

  • Protease Inhibitors (Pis)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis)
  • Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (Nrtis)
  • Entry or Fusion Inhibitors
  • Integrase Inhibitors
  • Others

By End User

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the HIV Diagnosis and Treatment Market By Test Type, By Diagnostic Product, By Treatment, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  HIV Diagnosis and Treatment Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of HIV Diagnosis and Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.  HIV Diagnosis and Treatment Market Analysis Tools

    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   HIV Diagnostic Product and Treatment Market, By Test Type Historical Analysis and Forecast 2025-2033 (USD Million)

    •   1. Antibody Tests
         1.1. Hiv-1 Screening Tests
         1.2. Hiv-1 Antibody Confirmatory Tests
         1.3. Hiv-2 and Group O Diagnostic Tests
        2. Viral Identification Assays
        3. Cd4 Testing
        4. Viral Load Testing
        5. Early Infant Diagnostics

  • 8.   HIV Diagnostic Product and Treatment Market, By Diagnostic Product Historical Analysis and Forecast 2025-2033 (USD Million)

    •   1. Assays, Kits and Reagents
        2. Instruments
        3. Software and Service
        4. Others (Poc and Single Blood Drop Analyser)

  • 9.   HIV Diagnostic Product and Treatment Market, By Treatment Historical Analysis and Forecast 2025-2033 (USD Million)

    •   1. Protease Inhibitors (Pis)
        2. Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis)
        3. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (Nrtis)
        4. Entry or Fusion Inhibitors
        5. Integrase Inhibitors
        6. Others

  • 10.   HIV Diagnostic Product and Treatment Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)

    •   1. Diagnostic Laboratories
        2. Hospitals
        3. Blood Banks
        4. Home Care Settings
        5. Other End Users

  • 11.   North America HIV Diagnostic Product and Treatment Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 12.   Latin America HIV Diagnostic Product and Treatment Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 13.   Europe HIV Diagnostic Product and Treatment Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 14.   Asia Pacific HIV Diagnostic Product and Treatment Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 15.   Middle East and Africa HIV Diagnostic Product and Treatment Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Types Offered and Financial Layouts)

    •   1. Viiv Healthcare Group of Companies, Inc.
         1.1. Company Overview
         1.2. Product Type Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boehringer Ingelheim Gmbh
         2.1. Company Overview
         2.2. Product Type Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bristol-Myers Squibb Company
         3.1. Company Overview
         3.2. Product Type Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. PathoFinder BV
         4.1. Company Overview
         4.2. Product Type Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. F. Hoffmann-La Roche Ltd
         5.1. Company Overview
         5.2. Product Type Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Gilead
         6.1. Company Overview
         6.2. Product Type Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Glaxosmithkline Plc.
         7.1. Company Overview
         7.2. Product Type Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hologic Inc.
         8.1. Company Overview
         8.2. Product Type Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Viiv Healthcare Group of Companies, Inc.
         9.1. Company Overview
         9.2. Product Type Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Janssen Diagnostics
         10.1. Company Overview
         10.2. Product Type Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Johnson & Johnson Services
         11.1. Company Overview
         11.2. Product Type Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Merck & Co. Inc.
         12.1. Company Overview
         12.2. Product Type Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Mylan Inc.
         13.1. Company Overview
         13.2. Product Type Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Qiagen
         14.1. Company Overview
         14.2. Product Type Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Roche Diagnostics
         15.1. Company Overview
         15.2. Product Type Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Partec
         16.1. Company Overview
         16.2. Product Type Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Pointcare Technologies Inc.
         17.1. Company Overview
         17.2. Product Type Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Siemens Healthcare
         18.1. Company Overview
         18.2. Product Type Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Sysmex Corporation
         19.1. Company Overview
         19.2. Product Type Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Zyomyx Inc.
         20.1. Company Overview
         20.2. Product Type Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 113 519 7222
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11